Identification and characterization of new structural scaffolds modulating the activity of Mycobacterium tuberculosis dihydroneopterin aldolase (FolB) in vitro

IntroductionAntifolates were among the first broad-spectrum compounds used as antimycobacterial agents and can still be of use when no other therapeutic options are available. The discovery of compounds targeting the essential folate synthesis pathway could lead to new therapeutic agents to treat tu...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Virginia Carla de Almeida Falcão, Alexia de Matos Czeczot, Mohammad Maqusood Alam, Kyu-Ho Paul Park, Jinyeong Heo, Minjeong Woo, Ana Micaela Camini, Luis Fernando Saraiva Macedo Timmers, David Shum, Marcia Alberton Perelló, Luiz Augusto Basso, Pablo Machado, Cristiano Valim Bizarro, Vincent Delorme
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2024-06-01
Rangatū:	Frontiers in Tropical Diseases
Ngā marau:	Mycobacterium tuberculosis dihydroneopterin aldolase (DHNA) Rv3607c (FolB) folate precursor synthesis drug screening
Urunga tuihono:	https://www.frontiersin.org/articles/10.3389/fitd.2024.1402321/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!